CLNT [Cleantech Solutions International,] NT 10-K: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING T ¨ ¨ ¨ ¨ ¨ ¨ ¨ ¨ ¨ PART I Cleantech Solutions International, Inc. No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China PART II T (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without]

CLNT [Cleantech Solutions International,] NT 10-K: FORM 12b-25 NOTIFICATION OF LATE FILING T ¨

[FORM 12b-25 NOTIFICATION OF LATE FILING T ¨ ¨ ¨ ¨ ¨ ¨ ¨ ¨ ¨ PART I Cleantech Solutions International, Inc. No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China PART II T (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without]

EVK [Ever-Glory International,] NT 10-K: FORM 12b-25 NOTIFICATION OF LATE FILING (Check One):

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x o o o o o December 31, 2012 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. If the notification relates to a portion of the filing checked]

BSPM [Biostar Pharmaceuticals,] NT 10-K: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x o o o o o December 31, 2012 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Read attached instruction sheet before preparing form. Please print or type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.]

By | 2016-03-03T11:24:15+00:00 April 1st, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] NT 10-K: FORM 12b-25 NOTIFICATION OF LATE FILING (Check One):

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x o o o o o December 31, 2012 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Read attached instruction sheet before preparing form. Please print or type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.]

By | 2016-03-03T11:25:22+00:00 April 1st, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CLNT [Cleantech Solutions International,] NT 10-K: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING PART I Cleantech Solutions International, No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China PART II T (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense;]

CLNT [Cleantech Solutions International,] NT 10-K: FORM 12b-25 NOTIFICATION OF LATE FILING PART I

[FORM 12b-25 NOTIFICATION OF LATE FILING PART I Cleantech Solutions International, No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China PART II T (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense;]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: (Original Filing)

[TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED DECEMBER 31, 2012 Page PART I Item 1. Business 2 Item 1A. Risk Factors 10 Item 1B. Unresolved Staff Comments 19 Item 2. Properties 19 Item 3. Legal Proceedings 20 Item 4. Mine Safety Disclosures 21 PART II Item 5. 21 Item 7. Management’s Discussion and Analysis of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. April 1, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. April 1, 2013 Bing Mei Chief Financial Officer]

By | 2016-03-01T04:22:29+00:00 April 1st, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Skip to toolbar